Abiopharma

🔍 Selting-Buchberger Joy (Executive)

Company: Marathon Bancorp, Inc. /MD/ (MBBC)

Report Date: 2026-06-28

Detailed Transactions and Holdings:

• Sold 522 shares of Common Stock at $15.49 per share (Direct)
  Date: 2026-06-28 | Code: F | equity_swap_involved: 0 | shares_owned_after: 4,760.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-28 | Code: H | nature_of_ownership: By 401(k) | shares_owned_after: 21,788.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-28 | Code: H | nature_of_ownership: By ESOP | shares_owned_after: 2,177.00 | Footnotes: F3
• Holds 5,999 shares of Stock Options at $8.13 per share (Derivative)
  Date: 2026-06-28 | Code: H | Expires: 2032-06-28 | Exercise: 2023-06-28 | shares_owned_after: 5,999.00 | Footnotes: F4, F4
• Holds 4,804 shares of Stock Options at $6.48 per share (Derivative)
  Date: 2026-06-28 | Code: H | Expires: 2033-05-16 | Exercise: 2024-05-16 | shares_owned_after: 4,804.00 | Footnotes: F5, F5

Footnotes:

• F1: Includes shares of restricted stock which vest at a rate of 20% per year commencing on June 28, 2023.
• F2: Includes shares of restricted stock which vest at a rate of 20% per year commencing on May 16, 2024.
• F3: Reflects transactions not required to be reported pursuant to Section 16 of the Securities Exchange Act of 1934, as amended.
• F4: Stock options vest at a rate of 20% per year commencing on June 28, 2023.
• F5: Stock options vest at a rate of 20% per year commencing on May 16, 2024.